Herndon Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$120K Buy
+3,759
New +$119K 0.02% 57
2016
Q4
Sell
-589
Closed -$19K 461
2016
Q3
$19K Hold
589
﹤0.01% 142
2016
Q2
$20K Buy
+589
New +$18.8K ﹤0.01% 168

Other funds holding PFE

Herndon Capital Management's PFE Position: Q2 2017 in Review

Herndon Capital Management opened a new position in Pfizer (PFE) in Q2 2017: 3,759 shares worth $120K. The stake represents 0.02% of the portfolio and ranks #57 among its holdings. This is a return to the name: Herndon Capital Management previously reported a position in PFE as recently as Q3 2016.

Herndon Capital Management first reported a position in PFE in Q2 2016 and has held it in 3 quarters since. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

  • Herndon Capital Management held 3,759 shares of Pfizer worth $120K as of Q2 2017.
  • Pfizer was a new Herndon Capital Management position in Q2 2017.
  • Pfizer made up 0.02% of Herndon Capital Management's portfolio in Q2 2017, its #57 holding.
  • Herndon Capital Management first reported a position in Pfizer in Q2 2016 and has held it in 3 quarters since.
  • 2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Herndon Capital Management's 13F filing for Q2 2017, filed 4 Aug 2017.